Bengaluru, November 13, 2025 – Apollo Cancer Centre (ACC) on Bannerghatta Road, Bengaluru, has announced a major expansion of its comprehensive cancer and haematology care with the launch of its dedicated Apollo Cellular Therapy and Blood and Marrow Transplant (BMT) Center.
This state-of-the-art facility is designed to bring a range of advanced cellular therapies and transplant modalities under one roof, making world-class, evidence-based treatment more accessible to patients in Karnataka and neighboring regions.
Advancing Cancer & Blood Disorder Treatment
The new centre marks a significant commitment by Apollo to harness the power of cellular therapy, including BMT, to fight complex diseases.
- Comprehensive Care: The unit will treat a wide spectrum of conditions, including leukaemia, lymphoma, multiple myeloma, aplastic anaemia, and thalassemia.
- Expert Team: It is supported by an experienced, multidisciplinary team of haematologists, oncologists, infectious disease specialists, and critical care experts.
- Focus on Precision: The centre emphasizes protocol fidelity, rigorous infection-control systems, and academic oversight to ensure the safest and most consistent outcomes.
Dr. Neema Bhat, Senior Consultant Hematology BMT Physician and Paediatric Oncology, highlighted the impact:
“This launch is a significant step in making high-end cancer care more accessible in Karnataka. By providing advanced treatment options, the centre aims to improve survival outcomes and quality of life for our patients with complex hematologic disorders.”
The Future of Treatment
Leaders at the launch event stressed the strategic importance of this new centre:
Harnessing the Body’s Cells: Prof. Dr. Vijay Agarwal, Senior and Lead consultant – Medical Oncology, noted, “The future of cancer treatment lies in harnessing the body’s own cells to fight disease. We are creating an ecosystem that combines advanced research, clinical expertise, and compassionate care.”
Reducing Patient Strain: Dr. Poonam Maurya, Senior consultant Medical Oncology and Hemato Oncology, pointed out the centre’s integrated approach will substantially reduce the logistical and emotional strain on families by streamlining diagnostics, transplant services, and follow-up care.
Meeting Complex Demands: Dr. Aditya Murali, Senior Consultant – Medical Oncology and Haemato oncology, emphasized the need for controlled environments and strict protocols required to deliver evolving cellular therapies, from allogeneic to sophisticated immune-engineered interventions.
Mr. Akshay Oleti, CEO – Karnataka Region, Apollo Hospitals, reinforced the commitment:
“The launch of this state-of-the-art Centre is a testament to our focus on enhancing Karnataka’s healthcare infrastructure. Our endeavour is to ensure that every patient receives world-class care within their own state.”
Expanding Apollo’s Legacy
The Bengaluru facility extends Apollo’s proven cellular therapy and BMT expertise—which includes successful units in Chennai, Hyderabad, and Visakhapatnam—reinforcing its position as a leading destination for advanced cancer and haematology care in India.
